Audientes partners with Medtronic LABS’ ear care program, Shruti, to expand distribution network in India.
Audientes A/S and one of India’s largest outreach programs in ear care, Medtronic LABS’ Shruti, today announced a partnership for the dispensing and sale of Audientes' self-fitting hearing aid, Ven™ by Audientes, in cities covered by the Shruti program, such as Delhi, Gurgaon, Faridabad, Hyderabad, Aurangabad, Jaipur, Raipur, Amritsar, Chennai and Dhaka (Bangladesh).
The partnership will help distribute and sell Ven to deserving clients in densely populated, low-income urban settlements as well as rural areas throughout India. Shruti was launched by Medtronic LABS in 2013 with a goal to create a sustainable program of low-cost ear and hearing care including awareness, screening, diagnosis, and treatment to communities in need. This agreement means that Audientes has now added an additional channel to its distribution network, which also includes hearing clinics and pharmacies.
A hearing care program with social impact
“We are delighted to now count Medtronic LABS’ ear care program, Shruti among our channel partners. At Audientes, our goal is to make our high-quality, self-fitting hearing aids accessible and affordable for everyone who needs them. Medtronic LABS’ Shruti is exactly the type of partner that can help us achieve this. Medtronic LABS launched Shruti with the philosophy to create a hearing care program with social impact – providing hearing care for those in need. It’s a hallmark example of health system innovation, serving the dual objects of social impact and business viability simultaneously. We are very proud to count them among our distribution channels,” says Steen Thygesen, CEO, Audientes A/S.
Providing low-cost otology care
Mr. Krishna Chandran, Market Development Lead of Medtronic LABS’ Shruti in India comments: “We are pleased to add the Audientes Ven hearing device to our solutions portfolio, and I am looking forward to introducing it to our patients. At Medtronic LABS’ ear car program Shruti, providing low-cost otology awareness and care to people in underserved communities is our goal. Through the Shruti program, we have been able to screen upwards of 1 million patients. Ven is an attractive offering for us for several reasons, primarily the price point, the built-in fitting, and the quality of the device. We are looking forward to introducing it to our clients.”
Medtronic LABS – Shruti is expected to commence sales of Ven in Q4 2022.
This investor news will not change the 2022 financial guidance for revenue and EBITDA results.
Mr. Steen Thygesen, CEO
Audientes A/S
Phone: +45 53 17 26 10
Email: st@audientes.com
Mr. Raman PV Rao, Country Head
Audientes India Pvt. Ltd. Phone: + 91 91770 49678
Email: rr@audientes.com
Mr. Krishna Chandran, Market Development Lead
Medtronic Labs – Shruti, India
Phone: + +91 99457 88666
Email: krishna.chandran@medtronic.com
About Audientes A/S
Audientes A/S is a Danish technology company specializing in smart, self-fitting and affordable hearing aids. Audientes’ unique hearing aid solution, Ven™ by Audientes, is available for purchase in the Indian market, online and in retail, and will be introduced to the US over-the-counter market and other markets in the coming years. Audientes’ mission is to help the approximately 500 million people globally suffering from disabling hearing loss who either cannot afford to buy one of the very expensive hearing aids on the market, or who do not currently have access to a solution to their hearing loss.
Audientes is listed on Spotlight Stock Market Denmark (AUDNTS) and headquartered in Copenhagen, Denmark with a subsidiary in Hyderabad, India.
For additional information please refer to the company’s websites, www.audientes.com or www.audientes.in
About Medtronic Labs’ ear care program Shruti
Medtronic Labs launched Medtronic Labs’ Shruti in July 2013 with a philosophy to create a sustainable program of low-cost otology care, including awareness, screening, diagnosis and treatment to the underserved, particularly in densely populated, low-income urban settlements and rural areas by leveraging medical technology, telecommunication and frugal innovation. With an ENT surgeon as the central point of care, the programs are operationalized through trained community health workers equipped with an ear screening kit. Patients with a positive provisional diagnosis are routed to the point of care for receiving low-cost treatment, including advanced diagnosis, medicines, audiometric tests, surgical interventions and hearing devices.
Medtronic is a global leader in healthcare technology, services and solutions.
For additional information, please refer to the company’s website, https://www.medtronic.com/in-en/about/plc.html